Arabic
Chinese (Simplified)
Dutch
English
French
German
Greek
Hebrew
Italian
Japanese
Korean
Persian
Portuguese
Russian
Spanish
Turkish
UrduFurther Evaluation of Therapeutic Efficacy of Dapsone in Cutaneous Leishmaniasis
KK Singh, BB Lal, P Rajvanshi, RD Mukhija, L Mohan
,
Correspondence Address:
K K Singh
Correspondence Address:
K K Singh
| How to cite this article: Singh K K, Lal B B, Rajvanshi P, Mukhija R D, Mohan L. Further Evaluation of Therapeutic Efficacy of Dapsone in Cutaneous Leishmaniasis. Indian J Dermatol Venereol Leprol 1991;57:96-97 |
Copyright: (C)1991 Indian Journal of Dermatology, Venereology, and Leprology
Abstract
Thirty four patients of cutaneous Leishmaniasis had received dapsone as treatment. The dose was approximately 2 mg per kilogram body weight per day. The duration of the treatment ranged from 14 to 63 days with the mean of 31.18 days. Twenty two patients (64.70%) had shown complete healing. Four patients (11.76%) did not show any response. Ulcerative variety (95.23%) responded fully, whereas nodular variety (15.38%) had poor response. No recurrence was seen during a follow up examination of 9 months.
